Global Immunoinformatics Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 103

Report ID: 3545

Immunoinformatics is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.
In 2018, the global Immunoinformatics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Immunoinformatics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunoinformatics development in United States, Europe and China.

The key players covered in this study
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co

Market segment by Type, the product can be split into
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling

Market segment by Application, split into
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology Of Immune Epitopes
Immune Epitope Database

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Immunoinformatics status, future forecast, growth opportunity, key market and key players.
To present the Immunoinformatics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Immunoinformatics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immunoinformatics Market Size Growth Rate by Type (2014-2025)
1.4.2 Cancer Diagnosis & Therapy
1.4.3 Reverse Vaccinology
1.4.4 Immune System Modeling
1.5 Market by Application
1.5.1 Global Immunoinformatics Market Share by Application (2014-2025)
1.5.2 Allergy Prediction Databases
1.5.3 Analysis Resource Database
1.5.4 International Immunogenetics System
1.5.5 The Ontology Of Immune Epitopes
1.5.6 Immune Epitope Database
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Immunoinformatics Market Size
2.2 Immunoinformatics Growth Trends by Regions
2.2.1 Immunoinformatics Market Size by Regions (2014-2025)
2.2.2 Immunoinformatics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Immunoinformatics Market Size by Manufacturers
3.1.1 Global Immunoinformatics Revenue by Manufacturers (2014-2019)
3.1.2 Global Immunoinformatics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Immunoinformatics Market Concentration Ratio (CR5 and HHI)
3.2 Immunoinformatics Key Players Head office and Area Served
3.3 Key Players Immunoinformatics Product/Solution/Service
3.4 Date of Enter into Immunoinformatics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Immunoinformatics Market Size by Type (2014-2019)
4.2 Global Immunoinformatics Market Size by Application (2014-2019)

5 United States
5.1 United States Immunoinformatics Market Size (2014-2019)
5.2 Immunoinformatics Key Players in United States
5.3 United States Immunoinformatics Market Size by Type
5.4 United States Immunoinformatics Market Size by Application

6 Europe
6.1 Europe Immunoinformatics Market Size (2014-2019)
6.2 Immunoinformatics Key Players in Europe
6.3 Europe Immunoinformatics Market Size by Type
6.4 Europe Immunoinformatics Market Size by Application

7 China
7.1 China Immunoinformatics Market Size (2014-2019)
7.2 Immunoinformatics Key Players in China
7.3 China Immunoinformatics Market Size by Type
7.4 China Immunoinformatics Market Size by Application

8 Japan
8.1 Japan Immunoinformatics Market Size (2014-2019)
8.2 Immunoinformatics Key Players in Japan
8.3 Japan Immunoinformatics Market Size by Type
8.4 Japan Immunoinformatics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Immunoinformatics Market Size (2014-2019)
9.2 Immunoinformatics Key Players in Southeast Asia
9.3 Southeast Asia Immunoinformatics Market Size by Type
9.4 Southeast Asia Immunoinformatics Market Size by Application

10 India
10.1 India Immunoinformatics Market Size (2014-2019)
10.2 Immunoinformatics Key Players in India
10.3 India Immunoinformatics Market Size by Type
10.4 India Immunoinformatics Market Size by Application

11 Central & South America
11.1 Central & South America Immunoinformatics Market Size (2014-2019)
11.2 Immunoinformatics Key Players in Central & South America
11.3 Central & South America Immunoinformatics Market Size by Type
11.4 Central & South America Immunoinformatics Market Size by Application

12 International Players Profiles
12.1 EpiVax
12.1.1 EpiVax Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immunoinformatics Introduction
12.1.4 EpiVax Revenue in Immunoinformatics Business (2014-2019)
12.1.5 EpiVax Recent Development
12.2 Novozymes Biopharma
12.2.1 Novozymes Biopharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immunoinformatics Introduction
12.2.4 Novozymes Biopharma Revenue in Immunoinformatics Business (2014-2019)
12.2.5 Novozymes Biopharma Recent Development
12.3 ioGenetics
12.3.1 ioGenetics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immunoinformatics Introduction
12.3.4 ioGenetics Revenue in Immunoinformatics Business (2014-2019)
12.3.5 ioGenetics Recent Development
12.4 International Society of Vaccines
12.4.1 International Society of Vaccines Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immunoinformatics Introduction
12.4.4 International Society of Vaccines Revenue in Immunoinformatics Business (2014-2019)
12.4.5 International Society of Vaccines Recent Development
12.5 IMGT
12.5.1 IMGT Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immunoinformatics Introduction
12.5.4 IMGT Revenue in Immunoinformatics Business (2014-2019)
12.5.5 IMGT Recent Development
12.6 Dassault Systemes
12.6.1 Dassault Systemes Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immunoinformatics Introduction
12.6.4 Dassault Systemes Revenue in Immunoinformatics Business (2014-2019)
12.6.5 Dassault Systemes Recent Development
12.7 Certara
12.7.1 Certara Company Details
12.7.2 Company Description and Business Overview
12.7.3 Immunoinformatics Introduction
12.7.4 Certara Revenue in Immunoinformatics Business (2014-2019)
12.7.5 Certara Recent Development
12.8 Chemical Computing Group
12.8.1 Chemical Computing Group Company Details
12.8.2 Company Description and Business Overview
12.8.3 Immunoinformatics Introduction
12.8.4 Chemical Computing Group Revenue in Immunoinformatics Business (2014-2019)
12.8.5 Chemical Computing Group Recent Development
12.9 Compugen
12.9.1 Compugen Company Details
12.9.2 Company Description and Business Overview
12.9.3 Immunoinformatics Introduction
12.9.4 Compugen Revenue in Immunoinformatics Business (2014-2019)
12.9.5 Compugen Recent Development
12.10 Genedata AG
12.10.1 Genedata AG Company Details
12.10.2 Company Description and Business Overview
12.10.3 Immunoinformatics Introduction
12.10.4 Genedata AG Revenue in Immunoinformatics Business (2014-2019)
12.10.5 Genedata AG Recent Development
12.11 Insilico Biotechnology AG
12.12 Leadscope Inc
12.13 Nimbus Discovery
12.14 Strand Life Sciences
12.15 Schrodinger
12.16 Simulation Plus
12.17 Rosa & Co

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details